VCP
GH icon

Verus Capital Partners’s Guardant Health GH Stock Holding History

Verus Capital Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$7K Hold
100
– – ﹤0.01% 1094
2019
Q4 		$8K Buy
+100
New +$7.21K ﹤0.01% 1199

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Verus Capital Partners's GH Position: Q1 2020 in Review

Verus Capital Partners held its Guardant Health (GH) position steady in Q1 2020 at 100 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

Verus Capital Partners first reported a position in GH in Q4 2019 and has held it in 2 quarters since. The position peaked at $8K in Q4 2019. 288 funds tracked by Wall St. Rank hold GH as of Q1 2020.

  • Verus Capital Partners held 100 shares of Guardant Health worth $7K as of Q1 2020.
  • Verus Capital Partners left its Guardant Health share count unchanged in Q1 2020.
  • Guardant Health made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1094 holding.
  • Verus Capital Partners first reported a position in Guardant Health in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Guardant Health position peaked at $8K in Q4 2019.
  • 288 funds tracked by Wall St. Rank held Guardant Health as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.